Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Urol ; 21(4): 401-7, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24147536

RESUMO

OBJECTIVES: To evaluate a novel designed degradable ureteral stent. METHODS: A total of 24 male Beagles, each with bilateral stents implanted (a biodegradable ureteral 4.5-Fr stent and a standard 4-Fr biostable stent) were divided into four groups. Intravenous pyelography, B-mode ultrasonography, and blood and urine tests were carried out before the procedure (0 weeks), and at 1-, 2-, 3- and 4-week intervals. Meanwhile, the mechanical characteristics of stents were tested, and scanning electron microscopy images of the biodegradable braided stents were obtained at different time-points postoperatively. In addition, histopathological changes were compared between the two different stents. RESULTS: All biodegradable braided stents began degrading at 1 week, and had completely degraded by 4 weeks. Hydronephrosis was equivalent during the first 2 weeks, but less with the biodegradable stents than with the control biostable stents at 3 and 4 weeks. Preoperative and postoperative blood and urine results were similar. The mechanical properties of the biodegradable stents were better than conventional biostable stents. Scanning electron microscopy images obtained at different weekly intervals showed that stents degraded in a predictable fashion. Histological testing of the urinary tract showed that the stent-related tissue reactivity of the two different stents were similar. CONCLUSIONS: Our novel braided thin-walled biodegradable stents provide temporary renal drainage as good as commercially available biostable stents. They also have good biocompatibility and physical characteristics. Therefore, they might have clinical application.


Assuntos
Implantes Absorvíveis/efeitos adversos , Hidronefrose/etiologia , Desenho de Prótese , Stents/efeitos adversos , Ureter/cirurgia , Animais , Sulfato de Bário , Cães , Hidronefrose/diagnóstico por imagem , Masculino , Microscopia Eletrônica de Varredura , Projetos Piloto , Radiografia , Distribuição Aleatória , Ureter/diagnóstico por imagem
2.
Neuroreport ; 15(14): 2167-72, 2004 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-15371726

RESUMO

Autografts have been extensively studied to facilitate optic nerve (ON) regeneration in animal experiments, but the clinical application of this approach to aid autoregeneration has not yet been attempted. This study aims to explore the guided regeneration by an artificial polyglycolic acid-chitosan conduit coated with recombinant L1-Fc. Consistent with previous studies; in vitro assay showed that both chitosan, a natural biomaterial, and the neural cell adhesion molecule L1-Fc enhanced neurite outgrowth. Rat optic nerve transection was used as an in vivo model. The implanted PGA-chitosan conduit was progressively degraded and absorbed, accompanied by significant axonal regeneration as revealed by immunohistochemistry, anterograde and retrograde tracing. The polyglycolic acid-chitosan conduit coated with L1-Fc showed more effective to promote axonal regeneration and remyelination. Taken together, our observations demonstrated that the L1-Fc coated PGA-chitosan conduits provided a compatible and supportive canal to guild the injured nerve regeneration and remyelination.


Assuntos
Quitosana/uso terapêutico , Regeneração Nervosa/efeitos dos fármacos , Molécula L1 de Adesão de Célula Nervosa/uso terapêutico , Traumatismos do Nervo Óptico/tratamento farmacológico , Ácido Poliglicólico/uso terapêutico , Animais , Materiais Biocompatíveis/uso terapêutico , Linhagem Celular Tumoral , Feminino , Regeneração Nervosa/fisiologia , Nervo Óptico/citologia , Nervo Óptico/efeitos dos fármacos , Nervo Óptico/fisiologia , Traumatismos do Nervo Óptico/patologia , Ratos , Ratos Wistar , Proteínas Recombinantes/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...